Sign in

You're signed outSign in or to get full access.

Mario Pinho

Chief Financial Officer at MARIMED
Executive

About Mario Pinho

Mario Pinho, 57, has served as MariMed’s Chief Financial Officer since August 9, 2024; he is a Certified Public Accountant with ~25 years of experience across FP&A, accounting, tax, procurement, treasury, M&A, systems, and process improvement, and holds a B.A. in Economics and Political Science from the University of Toronto . He previously held executive finance roles at Rakuten USA (CFO since 2016), was VP & Controller of Global Merchant Services at American Express (2008–2012), Senior Manager in KPMG’s Department of Professional Practice, and Manager, Internal Audit at AGF Management Limited; he resides in the Boston area and works from MariMed’s Norwood, MA headquarters . Company- or role-specific TSR, revenue growth, and EBITDA growth metrics tied to his performance are not disclosed in the 2025 proxy; the Compensation Committee oversees objectives and payouts but no metric framework is provided .

Past Roles

OrganizationRoleYearsStrategic Impact
Rakuten USACFO; prior executive finance roles2012–2024; CFO 2016–2024 Led financial reporting, FP&A, M&A, SOX reporting, investor relations; systems/process implementations
American ExpressVP & Controller, Global Merchant Services2008–2012 Oversight of controllership for global merchant services
KPMG LLPSenior Manager, Department of Professional Practice2006–2008 Technical accounting and audit quality in DPP
AGF Management LimitedManager, Internal Audit1998–2000 Internal controls and audit for asset management firm

External Roles

OrganizationRoleYearsNotes
The Filomen M. D’Agostino Greenberg Music School (501(c)(3))Board DirectorCurrent (as disclosed) Non-profit in New York; public charity designation

Fixed Compensation

Item2024Notes
Annual base compensation (rate)$265,000 Established upon CFO appointment
Salary paid$122,308 Partial year (joined July 2024)
All other compensation$6,223 Company-paid insurance premiums
Target bonus opportunity30% of base salary Performance bonus eligibility

Performance Compensation

Annual Bonus (2024)

MetricWeightingTargetActualPayout FormVesting
Annual bonus (program details not disclosed) Not disclosed 30% of base salary $5,305 48,226 RSUs to be issued in Q2 2025 Not disclosed

The proxy discloses bonus amounts and payout form but does not provide the underlying performance metrics or vesting provisions for 2024 RSU bonus awards .

Equity Awards (RSUs)

TypeGrant DateSharesGrant Date Fair ValueVesting Schedule
Inducement RSUs (upon CFO appointment)July 2024 300,000 $48,900 100,020 on Jul 17, 2025; 49,995 on Jan 15, 2026; 49,995 on Jul 15, 2026; 49,995 on Jan 15, 2027; 49,995 on Jul 15, 2027

Equity Ownership & Alignment

ItemAmountAs ofNotes
Total beneficial ownership (shares)35,009 Record Date: Apr 15, 2025 Less than 1% of common shares outstanding
Shares outstanding (denominator)388,709,677 Apr 15, 2025 Voting shares at Record Date
Unvested RSUs300,000 Dec 31, 2024 Detailed vesting dates shown below
Market value of unvested RSUs$34,800 Dec 31, 2024 (at $0.116/share) As disclosed under SEC rules
Options (exercisable/unexercisable)None disclosed Dec 31, 2024 No option holdings listed for Pinho
Shares pledged as collateralNot disclosed Insider policy prohibits hedging transactions (shorts, puts, calls) and requires pre-approval for trades; pledging is not addressed
Stock ownership guidelinesNot disclosed Awards under 2018 Plan subject to Company clawback policy

Vesting detail for unvested RSUs:

Vest DateShares
Jul 17, 2025100,020
Jan 15, 202649,995
Jul 15, 202649,995
Jan 15, 202749,995
Jul 15, 202749,995

Employment Terms

ComponentTerm
Title and effective dateCFO; effective August 9, 2024
Base salary$265,000 annually
Annual performance bonusEligible at 30% of base salary
Equity inducement300,000 RSUs subject to vesting
BenefitsEligible for company medical and other benefit plans
SeveranceNot disclosed for CFO; severance and CIC terms disclosed only for CEO/COO
Clawback2018 Plan awards subject to Company clawback policy
Trading policyInsider trading policy prohibits trading on MNPI; hedging (shorts, puts, calls) prohibited; pre-approval required for Named Executives

Investment Implications

  • Pay-for-performance alignment: CFO compensation features a modest base ($265k) with at-risk elements via annual bonus (30% target) and a multi-year RSU inducement grant; however, specific performance metrics and weightings for bonus determinations are not disclosed, limiting visibility into pay-performance rigor .
  • Vesting and potential supply overhang: A front-loaded RSU vest of ~100k shares in July 2025 followed by semiannual ~50k tranches through July 2027 sets predictable windows that could coincide with Form 4 activity; monitor insider filings around these dates for potential selling pressure signals .
  • Ownership alignment: Beneficial ownership is de minimis (<1%); alignment relies on unvested RSUs subject to company clawback policy rather than sizable direct holdings; no pledging disclosure and hedging is prohibited under policy .
  • Retention risk: Inducement RSUs vest over 2.0–3.0 years, supporting near-term retention; absence of disclosed CFO-specific severance/change-of-control protection suggests less structural retention leverage compared to CEO/COO contracts, though broad committee oversight remains active .
  • Governance context: The Compensation Committee is fully independent and administers equity/bonus plans; significant related-party transactions exist at the Company level (CEO/COO), which are overseen by the Audit Committee per policy—important backdrop for governance and control considerations .

Source documents: Appointment press release (Aug 7, 2024) ; 2025 DEF 14A (Apr 30, 2025) .